Discover how hybrid vectors, lipopolyplexes, and virus-like particles overcome stability and targeting barriers for mRNA delivery in preclinical research. Introduction Messenger RNA (mRNA)-based therapeutics have transformed the landscape of vaccine development, geneRead More…
Advances in mRNA Delivery: LNPs, Polymer Vectors and Micelleplexes
Explore advances in mRNA delivery, from lipid nanoparticles to polymer-based vectors, polyplexes and micelleplexes. Learn how tailored platforms support preclinical therapeutic development. Introduction Messenger RNA (mRNA) therapeutics have transitioned from a promisingRead More…
Beyond the Blueprint: The Double-Edged Sword of mRNA Chemical Engineering
The scientific community is currently witnessing a renaissance in therapeutics, driven by the remarkable success of messenger RNA (mRNA). While the fundamental premise of mRNA—delivering a cellular “instruction manual” to produce therapeuticRead More…
The Untapped Potential of Modified Cap & Nucleotides in Therapeutics
The therapeutic landscape has been irrevocably altered by the arrival of messenger RNA (mRNA) technology. The global success of mRNA-based COVID-19 vaccines was a watershed moment, proving not just the concept butRead More…
Beyond the Vaccine: Navigating the New Frontiers of mRNA Research and Pre-clinical Innovation
The landscape of modern medicine is undergoing a seismic shift. If the last decade was defined by the rise of monoclonal antibodies, the current era belongs to programmable nucleic acids. mRNA technology,Read More…
Strategies for Optimizing mRNA Lipid Nanoparticles and Novel Delivery Vectors
In the rapidly evolving landscape of biopharmaceuticals, messenger RNA (mRNA) therapeutics have emerged as a transformative class of drugs. From prophylactic vaccines to protein replacement therapies and cancer immunotherapies, the potential ofRead More…
Unlocking the Full Potential of mRNA Therapeutics
The biomedical landscape has shifted irrevocably. If the last decade was defined by the rise of biologics and monoclonal antibodies, the coming era belongs to messenger RNA (mRNA). From the rapid deploymentRead More…
Beyond the Liver: A New One-Component mRNA Delivery System Revolutionizes Cancer Vaccines
The remarkable clinical success of mRNA vaccines in preventing COVID-19, driven by their ability to rapidly induce robust immune responses, has paved the way for new frontiers in medicine. This success hasRead More…
The LNP Balancing Act: Optimizing mRNA Efficacy and Safety
The era of messenger RNA (mRNA) has arrived, transforming the landscape of vaccines and therapeutics. The rapid development and success of mRNA vaccines have been a landmark achievement in modern medicine. However,Read More…
Nature: Interstasis—The Nuclear Sensor That Stops Toxic Protein Condensation
The concentration of proteins containing intrinsically disordered regions (IDRs) must be tightly controlled to maintain cellular homeostasis. However, our understanding of the collective control mechanisms for these proteins—which tend to cluster inRead More…
